Correlation Between Cadrenal Therapeutics, and Cara Therapeutic

Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Cara Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Cara Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Cara Therapeutic, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Cara Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Cara Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Cara Therapeutic.

Diversification Opportunities for Cadrenal Therapeutics, and Cara Therapeutic

0.4

Correlation Coefficient

Cadrenal Therapeutics,  Cara Therapeutic

Very weak diversification

The 3 months correlation between Cadrenal and Cara is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Cara Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cara Therapeutic and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Cara Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cara Therapeutic has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Cara Therapeutic go up and down completely randomly.

Pair Corralation between Cadrenal Therapeutics, and Cara Therapeutic

Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to generate 7.2 times more return on investment than Cara Therapeutic. However, Cadrenal Therapeutics, is 7.2 times more volatile than Cara Therapeutic. It trades about 0.04 of its potential returns per unit of risk. Cara Therapeutic is currently generating about -0.08 per unit of risk. If you would invest  0.15  in Cadrenal Therapeutics, Common on September 13, 2024 and sell it today you would earn a total of  1,160  from holding Cadrenal Therapeutics, Common or generate 773233.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	96.77%
Values	Daily Returns

Cadrenal Therapeutics, Common  vs.  Cara Therapeutic

Cadrenal Therapeutics,

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Cadrenal Therapeutics, Common are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent forward-looking signals, Cadrenal Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cara Therapeutic

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cara Therapeutic are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Cara Therapeutic is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Cadrenal Therapeutics, and Cara Therapeutic

The main advantage of trading using opposite Cadrenal Therapeutics, and Cara Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Cara Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cara Therapeutic will offset losses from the drop in Cara Therapeutic's long position.

The idea behind Cadrenal Therapeutics, Common and Cara Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.